OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
|View All Citations >>||
Home All anti-SMAD4 antibodies
Anti-SMAD4 Antibody EP618Y
Also for SMAD4 (NM_005359)
|Homo sapiens SMAD family member 4 (SMAD4)|
|DPC4; JIP; MADH4; MYHRS|
|A synthetic peptide corresponding to residues in the C-term of human Smad 4 was used as immunogen.|
|50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.|
|Human, Mouse, Rat
|WB, IHC, IF
||WB: 1:1,000-5,000; IHC: 1:100-250; ICC: 1:100-250; FC: 1:20; IP: 1:30
Delta-Notch Signaling Pathway
TGF Beta Signaling Pathway
Wnt Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis on SHSY5Y cell lysate using anti-Smad 4 (C-term) RabMAb (TA303589), dilution 1:5,000.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using anti-SMAD4 (C-term) RabMAb (TA303589).
Immunofluorescent staining of HeLa cells using anti-SMAD4 (C-term) RabMAb (TA303589).